| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |